Illuminating the Dark Genome to enable drug discovery - J. Heward (Nucleome Tx)

Full Title: Illuminating the Dark Genome to enable drug discovery from human genetics

Genetic insights drive drug discovery, but common diseases pose challenges due to complex polygenic traits and unknown functionalities of many non-coding genome regions.

Through the use of deep-learning Nucleome Therapeutics pioneers the prediction of casual SNPs and then use proprietary MCC (Micro Capture-C technology) to unravel causal links between genetic variants and diseases. Systematically uncovering de-risked drug targets and promising breakthrough treatments for conditions like autoimmunity.

Please join us in welcoming James Heward from Nucleome Therapeutics who will guide us through these pioneering advancements in genetics for drug discovery!

Approximate schedule:

6:30: Doors open
6:45: Announcements and group updates
7:00: Start of the talk
7:45: Q&A, Pub time!